Retinal Pigment Epithelium Degeneration Caused by Aggregation of PRPF31 and the Role of HSP70 Family of Proteins Lourdes Valdés-Sánchez1†, Sofia M
Total Page:16
File Type:pdf, Size:1020Kb
Valdés-Sánchez et al. Molecular Medicine (2020) 26:1 Molecular Medicine https://doi.org/10.1186/s10020-019-0124-z RESEARCH ARTICLE Open Access Retinal pigment epithelium degeneration caused by aggregation of PRPF31 and the role of HSP70 family of proteins Lourdes Valdés-Sánchez1†, Sofia M. Calado1,2†, Berta de la Cerda1, Ana Aramburu1,3, Ana Belén García-Delgado1, Simone Massalini1,4, Adoración Montero-Sánchez1, Vaibhav Bhatia1, Eduardo Rodríguez-Bocanegra1,5, Andrea Diez-Lloret1, Daniel Rodríguez-Martínez1, Christina Chakarova6, Shom S. Bhattacharya6* and Francisco J. Díaz-Corrales1* Abstract Background: Mutations in pre-mRNA splicing factor PRPF31 can lead to retinitis pigmentosa (RP). Although the exact disease mechanism remains unknown, it has been hypothesized that haploinsufficiency might be involved in the pathophysiology of the disease. Methods: In this study, we have analyzed a mouse model containing the p.A216P mutation in Prpf31 gene. Results: We found that mutant Prpf31 protein produces cytoplasmic aggregates in the retinal pigment epithelium and decreasing the protein levels of this splicing factor in the nucleus. Additionally, normal protein was recruited in insoluble aggregates when the mutant protein was overexpressed in vitro. In response to protein aggregation, Hspa4l is overexpressed. This member of the HSP70 family of chaperones might contribute to the correct folding and solubilization of the mutant protein, allowing its translocation to the nucleus. Conclusions: Our data suggests that a mechanism haploinsufficiency and dominant-negative is involved in retinal degeneration due to mutations in PRPF31. HSP70 over-expression might be a new therapeutic target for the treatment of retinal degeneration due to PRPF31 mutations. Keywords: HSP70, PRPF31, Retinal degeneration, Retinal pigment epithelium, Retinitis pigmentosa Background night blindness, which usually starts during adoles- Retinitis pigmentosa (RP) is one of a diverse group of ret- cence and progresses with constriction of the visual inal dystrophies and one of the commonest causes of inher- field and a marked reduction in the amplitude of ited blindness in adults, affecting around 1:4000 individuals electroretinogram (ERG) waves. So far, mutations in worldwide (Verbakel et al., 2018). RP initially presents a more than 80 genes have been implicated in non- progressive impairment and cell death of rod photorecep- syndromic RP (Verbakel et al., 2018). Many of these tors, followed by loss of cones and retinal pigment genes encode for retinal-specific proteins; however, epithelium (RPE). Clinically, RP is characterized by some are ubiquitously expressed, such as splicing fac- tors PRPF3, PRPF4, PRPF6, PRPF8 and PRPF31 (Liu &Zack,2013; Ruzickova & Stanek, 2017). * Correspondence: [email protected]; [email protected] †Lourdes Valdés-Sánchez and Sofia M. Calado contributed equally to this Pre-mRNA splicing is a general cellular function cru- work. cial for the expression of eukaryotic transcripts. It is cat- 6Institute of Ophthalmology, University College London, 11-43 Bath Street, alyzed by the spliceosome, a large ribonucleoprotein London EC1V 9EL, UK 1Regeneration and Cell Therapy Department, Andalusian Molecular Biology complex composed of five small nuclear ribonucleopro- and Regenerative Medicine Centre-CABIMER (Junta de Andalucía), CSIC, tein complexes (Ruzickova & Stanek, 2017). In humans, Universidad de Sevilla, Universidad Pablo de Olavide, Avda. Americo PRPF31 encodes the homolog of S. cerevisiae pre- Vespucio 24, 41092 Seville, Spain Full list of author information is available at the end of the article mRNA processing factor 31, also known as PRPF31 © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Valdés-Sánchez et al. Molecular Medicine (2020) 26:1 Page 2 of 22 protein (Vithana et al., 2001). PRPF31 is required for modulation as a new therapeutic target for the treatment the U4/U6-U5 tri-snRNP formation and spliceosome of RP due to PRPF31 mutations. activity (Makarova et al., 2002; Schaffert et al., 2004). Mutations in PRPF31 have been described as the sec- Methods ond most common cause of autosomal dominant RP Animal handling and eye samples (adRP) known as RP11 (Vithana et al., 2001;Al- Eight to sixteen-month old C57BL/6 J Prpf31+/+ (WT) Maghtheh et al., 1998;Roseetal.,2016)and,al- and C57BL/6 J Prpf31A216P/+ (KI) mice were housed in though PRPF31 is necessary for pre-mRNA splicing in the Biological Resources Unit of CABIMER and kept in every cell, adRP is the only clinical entity associated a temperature-controlled environment (21 ± 1 °C), with a with these mutations. relative humidity of 55 ± 5%, a light/dark cycle 08:00–20: Curiously, within the PRPF31-affected families, it is 00 and given standard mouse chow and water ad libi- common to find asymptomatic carriers due to overex- tum. Mouse genotyping was performed as previously de- pression of the WT allele inherited from the normal par- scribed (Bujakowska et al., 2009). Due to homozygous ent. Therefore, the differential expression of the WT Prpf31A216P/A216P mice are not viable, we use allele explains the incomplete penetrance associated with Prpf31A216P/+ and Prpf31+/+ mice to obtain a similar pro- this RP locus (Rose et al., 2016; Vithana et al., 2003). It portion of KI and WT in each litter. The WT mice used has recently been described that the expression level of as controls in each experiment belonged to the same lit- PRPF31 is regulated by the number of copies of a minis- ter of the Prpf31A216P/+ mice. The rd8 mutants were dis- atellite repeat element-MSR1 located 200 bp upstream of carded in these mice using the specific primers: forward the promoter. High-expressing WT alleles are found in 5′-GCC CCT GTT TGC ATG GAG GAA ACT TGG asymptomatic carriers and low-expressing alleles are as- AAG ACA GTC ACA GTT CTT CTG-3′ and reverse sociated with the disease, where the amount of WT 5′-GCC CCA TTT GCA CAC TGA TGA C-3’ (Matta- PRPF31 protein produced is beneath its threshold for pallil et al., 2012). A group of WT CD-1 mice were also normal function (Rose et al., 2016). used for the immunohistochemistry experiments. Although haploinsufficiency contributes to the physio- All experiments described in this work were per- pathology of the disease, it is still not clear how retinal formed in compliance with the Spanish and European degeneration occurs in patients carrying PRPF31 muta- Laboratory Animal Science Association-FELASA Guide tions. To explore disease mechanisms, two animal for the Care and Use of Laboratory Animals, the Euro- models were previously generated (Bujakowska et al., pean Union Council Directive 2010/63/EU for the use of 2009). One was a heterozygous knockout (KO) mouse animals and the Association for Research in Vision and − (Prpf31+/ ) and the second a knock-in (KI) mouse carry- Ophthalmology-ARVO for the use of animals in oph- ing the point mutation p.A216P (Prpf31A216P/+). This thalmic and vision research. Animal manipulation and mutation was previously identified in RP11 patients with experimental methods have been approved by the Ethics a severe retinal phenotype (Vithana et al., 2001). How- Committee for Animal Experimentation of CABIMER, ever, both heterozygous mouse models did not show any Seville, Spain. All efforts were made to minimize the sign of photoreceptor degeneration and, as expected, the number of animals used and their suffering. Pig and cow homozygous mutant mice were found to be embryonic eye samples were obtained from a local slaughterhouse. lethal (Bujakowska et al., 2009). Based on these results, it Human eye sample for Western blotting was obtained was speculated that Prpf31 is essential for survival and from a deceased healthy donor, in a procedure approved the presence of one WT Prpf31 allele is enough to main- by the Ethics Committee of University Hospital Virgen tain retinal function with no dominant-negative effect of Macarena, Seville, Spain. the p.A216P mutation in mice. More recently, it has been published that three Immunohistochemistry and immunofluorescence splicing-factor mouse models (Prpf3T494M/+, experiments − Prpf8H2309P/+ and Prpf31+/ ) develop late-onset morpho- Immunohistochemistry was performed to evaluate distri- logical changes and dysfunction in the RPE rather than bution of Prpf31 protein in retinal sections of WT CD-1 photoreceptor degeneration (Farkas et al., 2014;Graziotto mice. The animals were euthanized by cervical disloca- et al., 2011). Therefore, in this work, we decided to study tion and the eyes excised quickly and fixed in ice-cold the effect of the p.A216P mutation on RPE. We found 4% paraformaldehyde (PFA) in PBS, overnight, at 4 °C. mislocalization and aggregation of the mutant Prpf31 pro- The fixed eyes were then cryoprotected in 30% sucrose tein with concomitant depletion of normal protein. These in PBS, and embedded in optimal cutting temperature results indicate mixed haploinsufficiency and dominant- compound for cryotome sections. Serial sections of negative mechanisms involved in retinal degeneration due 18 μm thick were mounted in five parallel series and to mutations in PRPF31. Also, this work postulates HSP70 processed for immunohistochemistry. Briefly, the retinal Valdés-Sánchez et al. Molecular Medicine (2020) 26:1 Page 3 of 22 sections were kept in 3% H2O2 in PBS for 30 min. Sam- Incubation with primary antibodies: goat anti-PRPF31 ples were then washed in 0.2% Triton X-100/PBS (PBS- (1:100; OriGene Technologies Inc., TA302582) and T) and blocked in 1% BSA/PBS-T at room temperature mouse anti-HSP70 (1:100; Santa Cruz Biotechnology, for 1 h.